Jubilant Life Sciences Ltd announces financial results for the quarter
The Board of Jubilant Life Sciences Limited, an integrated pharmaceutical and life sciences company met today to approve financial results […]
Say something
Tags: business, Business/Finance, Chairman & Managing Director, China, Co-Chairman & Managing Director, Earnings before interest taxes depreciation and amortization, Economy of India, europe, FDA, Finance, Health/Medical/Pharmaceuticals, Healthcare in India, income, investment, Japan, JUBILANT LIFE SCIENCES LIMITED, Montreal, North America, pharmaceutical, Pharmaceutical industry in India, Quality System, radiopharmaceuticals, Reorganization, Rs, Shyam S Bhartia
Investments in Indian healthcare to grow slowly in 2012, says Fitch
Fitch Ratings has come out with its report on Indian healthcare sector. In a recent report, the agency has classified […]
Biocon sees larger licensing income from pharma
Biocon , India’s top-listed biotechnology company, expects to generate larger licensing income from pharmaceuticals business, its Chairman and Managing Director […]
-
-
Flipkart Health+ App Launched
06-04-2022
